Idioma:

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

Salgado, R. ; Denkert, C. ; Demaria, S. ; Sirtaine, N. ; Klauschen, F. ; Pruneri, G. ; Wienert, S. ; Van den Eynden, G. ; Baehner, F.L. ; Penault-Llorca, F. ; Perez, E.A. ; Thompson, E.A. ; Symmans, W.F. ; Richardson, A.L. ; Brock, J. ; Criscitiello, C. ; Bailey, H. ; Ignatiadis, M. ; Floris, G. ; Sparano, J. ; Kos, Z. ; Nielsen, T. ; Rimm, D.L. ; Allison, K.H. ; Reis-Filho, J.S. ; Loibl, S. ; Sotiriou, C. ; Viale, G. ; Badve, S. ; Adams, S. ; Willard-Gallo, K. ; Loi, S.

Annals of oncology, 2015-02, Vol.26 (2), p.259-271 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível

Citações Citado por

Enviar para

Título:
The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014
Autor: Salgado, R. ; Denkert, C. ; Demaria, S. ; Sirtaine, N. ; Klauschen, F. ; Pruneri, G. ; Wienert, S. ; Van den Eynden, G. ; Baehner, F.L. ; Penault-Llorca, F. ; Perez, E.A. ; Thompson, E.A. ; Symmans, W.F. ; Richardson, A.L. ; Brock, J. ; Criscitiello, C. ; Bailey, H. ; Ignatiadis, M. ; Floris, G. ; Sparano, J. ; Kos, Z. ; Nielsen, T. ; Rimm, D.L. ; Allison, K.H. ; Reis-Filho, J.S. ; Loibl, S. ; Sotiriou, C. ; Viale, G. ; Badve, S. ; Adams, S. ; Willard-Gallo, K. ; Loi, S.
Assuntos: breast cancer (BC) ; Breast Neoplasms - immunology ; clinical validity ; Female ; Humans ; Lymphocytes, Tumor-Infiltrating ; prediction ; prognosis ; tumor-infiltrating lymphocytes (TILs)
É parte de: Annals of oncology, 2015-02, Vol.26 (2), p.259-271
Notas: ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Instructional Material/Guideline-2
ObjectType-Feature-3
content type line 23
These authors contributed equally to this manuscript.
Descrição: Evidence is strengthening for the morphological evaluation of tumor infiltrating lymphocytes (TILs) in breast cancer. Herein, the concepts for TILs assessment are laid out by pathologists to facilitate their wider evaluation and consistent interpretation. The goal of this article is to promote the evaluation of TILs as a biomarker in research, clinical trial settings and day-to-day practice. The morphological evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer (BC) is gaining momentum as evidence strengthens for the clinical relevance of this immunological biomarker. Accumulating evidence suggests that the extent of lymphocytic infiltration in tumor tissue can be assessed as a major parameter by evaluation of hematoxylin and eosin (H&E)-stained tumor sections. TILs have been shown to provide prognostic and potentially predictive value, particularly in triple-negative and human epidermal growth factor receptor 2-overexpressing BC. A standardized methodology for evaluating TILs is now needed as a prerequisite for integrating this parameter in standard histopathological practice, in a research setting as well as in clinical trials. This article reviews current data on the clinical validity and utility of TILs in BC in an effort to foster better knowledge and insight in this rapidly evolving field, and to develop a standardized methodology for visual assessment on H&E sections, acknowledging the future potential of molecular/multiplexed approaches. The methodology provided is sufficiently detailed to offer a uniformly applied, pragmatic starting point and improve consistency and reproducibility in the measurement of TILs for future studies.
Editor: England: Elsevier Ltd
Idioma: Inglês

Links

View this record in MEDLINE/PubMed

Voltar para lista de resultados

Realização: Logos de Redes Sociais:

The evaluation of tumor-infiltrating lymphocytes (TILs) in breast cancer: recommendations by an International TILs Working Group 2014

England: Elsevier Ltd

Buscando em bases de dados remotas. Favor aguardar.